Britain's AstraZeneca to buy 9.8 percent stake in France's Innate Pharma
PARIS (Reuters) – British drugmaker AstraZeneca will buy a newly issued equity stake of 9.8 percent in smaller French peer Innate Pharma, as consolidation intensifies in the healthcare sector. FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo AstraZeneca will buy the… Read More »